S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
NASDAQ:SWAV

Shockwave Medical (SWAV) Stock Forecast, Price & News

$194.48
-2.39 (-1.21%)
(As of 09/22/2023 ET)
Compare
Today's Range
$194.33
$199.86
50-Day Range
$194.49
$275.98
52-Week Range
$172.50
$320.54
Volume
425,312 shs
Average Volume
560,191 shs
Market Capitalization
$7.15 billion
P/E Ratio
30.29
Dividend Yield
N/A
Price Target
$292.29

Shockwave Medical MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.86 Rating Score
Upside/​Downside
50.3% Upside
$292.29 Price Target
Short Interest
Healthy
3.46% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.55
Upright™ Environmental Score
News Sentiment
0.43mentions of Shockwave Medical in the last 14 days
Based on 11 Articles This Week
Insider Trading
Selling Shares
$9.46 M Sold Last Quarter
Proj. Earnings Growth
20.78%
From $3.61 to $4.36 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.91 out of 5 stars

Medical Sector

46th out of 968 stocks

Surgical & Medical Instruments Industry

6th out of 90 stocks


SWAV stock logo

About Shockwave Medical (NASDAQ:SWAV) Stock

ShockWave Medical, Inc., a medical device company, develops intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters for use in our IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter for use in IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

SWAV Price History

SWAV Stock News Headlines

Multiple Headwinds Pushed Shockwave Medical (SWAV) in Q2
Multiple Tailwinds Pushed Shockwave Medical (SWAV) in Q2
WARNING: Seven millionaires to trigger sudden market panic?
The next major selloff could be just days away…And seven powerful (yet completely unknown) insiders will be behind it all – and help corporate executives make a killing as it plays out. Here’s the full story.
Don't Be Shocked if Shockwave Medical Keeps Heading South
WARNING: Seven millionaires to trigger sudden market panic?
The next major selloff could be just days away…And seven powerful (yet completely unknown) insiders will be behind it all – and help corporate executives make a killing as it plays out. Here’s the full story.
Here’s Why Shockwave Medical (SWAV) Outperformed in Q2
Bank of America Securities Remains a Buy on Shockwave Medical (SWAV)
Piper Sandler Sticks to Their Buy Rating for Shockwave Medical (SWAV)
Shockwave Medical (SWAV) Exceeded Expectations in Q2
Shockwave Medical: Not Worth The Price
Why Shockwave Medical Stock Dropped Today
See More Headlines
Receive SWAV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shockwave Medical and its competitors with MarketBeat's FREE daily newsletter.

SWAV Company Calendar

Last Earnings
8/07/2023
Today
9/22/2023
Next Earnings (Estimated)
11/06/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SWAV
Fax
N/A
Employees
1,001
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$292.29
High Stock Price Forecast
$330.00
Low Stock Price Forecast
$251.00
Forecasted Upside/Downside
+49.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.86
Research Coverage
7 Analysts

Profitability

Net Income
$216 million
Pretax Margin
24.90%

Debt

Sales & Book Value

Annual Sales
$489.73 million
Cash Flow
$5.87 per share
Book Value
$14.15 per share

Miscellaneous

Free Float
35,501,000
Market Cap
$7.19 billion
Optionable
Not Optionable
Beta
0.98
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Douglas E. Godshall M.B.A. (Age 58)
    Pres, CEO & Director
    Comp: $1.57M
  • Mr. Daniel Puckett MBA (Age 59)
    CFO, Principal Financial Officer & Sec.
    Comp: $797.38k
  • Mr. Isaac  ZachariasMr. Isaac Zacharias (Age 48)
    Chief Commercial Officer
    Comp: $908.02k
  • Mr. Daniel Hawkins (Age 56)
    Founder and Sr. Advisor
  • Mr. John M. Adams (Age 76)
    Co-Founder and Technical Advisor
  • Mr. Mike Maszy
    Sr. VP of Operations
  • Ms. Trinh  PhungMs. Trinh Phung (Age 45)
    Chief Accounting Officer & Principal Accounting Officer
  • Mr. Hajime Tada J.D.
    Gen. Counsel & Sec.
  • Mr. Robert Fletcher
    Sr. VP of Marketing & Market Access
  • Mr. Dave Cox
    VP of Sales













SWAV Stock - Frequently Asked Questions

Should I buy or sell Shockwave Medical stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Shockwave Medical in the last year. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" SWAV shares.
View SWAV analyst ratings
or view top-rated stocks.

What is Shockwave Medical's stock price forecast for 2023?

7 Wall Street research analysts have issued 12-month price objectives for Shockwave Medical's stock. Their SWAV share price forecasts range from $251.00 to $330.00. On average, they expect the company's stock price to reach $292.29 in the next year. This suggests a possible upside of 50.3% from the stock's current price.
View analysts price targets for SWAV
or view top-rated stocks among Wall Street analysts.

How have SWAV shares performed in 2023?

Shockwave Medical's stock was trading at $205.61 at the start of the year. Since then, SWAV shares have decreased by 5.4% and is now trading at $194.4850.
View the best growth stocks for 2023 here
.

When is Shockwave Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 6th 2023.
View our SWAV earnings forecast
.

How were Shockwave Medical's earnings last quarter?

Shockwave Medical, Inc. (NASDAQ:SWAV) issued its quarterly earnings results on Monday, August, 7th. The company reported $0.76 earnings per share for the quarter, missing the consensus estimate of $0.85 by $0.09. The business had revenue of $180.17 million for the quarter, compared to analysts' expectations of $173.79 million. Shockwave Medical had a trailing twelve-month return on equity of 47.48% and a net margin of 39.56%. The business's revenue for the quarter was up 49.2% on a year-over-year basis. During the same quarter last year, the company posted $0.68 earnings per share.

What guidance has Shockwave Medical issued on next quarter's earnings?

Shockwave Medical updated its FY 2023 earnings guidance on Monday, August, 7th. The company provided EPS guidance of for the period. The company issued revenue guidance of $725.00 million-$730.00 million, compared to the consensus revenue estimate of $716.10 million.

What is Doug Godshall's approval rating as Shockwave Medical's CEO?

8 employees have rated Shockwave Medical Chief Executive Officer Doug Godshall on Glassdoor.com. Doug Godshall has an approval rating of 89% among the company's employees.

What other stocks do shareholders of Shockwave Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Shockwave Medical investors own include NVIDIA (NVDA), Walt Disney (DIS), Block (SQ), Trade Desk (TTD), Salesforce (CRM), Roku (ROKU), PayPal (PYPL), DexCom (DXCM), Alibaba Group (BABA) and Okta (OKTA).

When did Shockwave Medical IPO?

(SWAV) raised $75 million in an initial public offering (IPO) on Thursday, March 7th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

What is Shockwave Medical's stock symbol?

Shockwave Medical trades on the NASDAQ under the ticker symbol "SWAV."

Who are Shockwave Medical's major shareholders?

Shockwave Medical's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Bank Julius Baer & Co. Ltd Zurich (10.15%), BlackRock Inc. (9.90%), Artisan Partners Limited Partnership (3.13%), State Street Corp (2.77%), Geode Capital Management LLC (1.54%) and Allspring Global Investments Holdings LLC (1.30%). Insiders that own company stock include Antoine Papiernik, Colin Cahill, Dan Puckett, Douglas Evan Godshall, Frank T Watkins, Frank T Watkins, Isaac Zacharias, Kurt F Gallo, Laura Francis, Maria Sainz, Sara Toyloy and Trinh Phung.
View institutional ownership trends
.

How do I buy shares of Shockwave Medical?

Shares of SWAV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Shockwave Medical's stock price today?

One share of SWAV stock can currently be purchased for approximately $194.49.

How much money does Shockwave Medical make?

Shockwave Medical (NASDAQ:SWAV) has a market capitalization of $7.15 billion and generates $489.73 million in revenue each year. The company earns $216 million in net income (profit) each year or $6.42 on an earnings per share basis.

How many employees does Shockwave Medical have?

The company employs 1,001 workers across the globe.

How can I contact Shockwave Medical?

Shockwave Medical's mailing address is 5403 Betsy Ross Drive, Santa Clara CA, 95054. The official website for the company is www.shockwavemedical.com. The company can be reached via phone at (877) 775-4846 or via email at investors@shockwavemedical.com.

This page (NASDAQ:SWAV) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -